Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ORYZON-GENOMICS-S-A-25531377/attualita/ORYZON-annuncia-l-approvazione-da-parte-della-FDA-degli-Stati-Uniti-dello-studio-clinico-di-Fase-I-I-46393637/?utm_source=whatsapp&utm_medium=social&utm_campaign=share